Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening

Abstract

Get full access to this article

View all access options for this article.

References

Takahashi

Prostate cancer screening: The level of the evidence hierarchy. J Med Screen. Epub ahead of print 8 May 2026. 10.1177/09691413261450117.

Takahashi

. Prostate cancer screening: evidence, endpoints, and expert opinion. J Prim Care Community Health. Epub ahead of print 5 February 2026. 10.1177/21501319261420570.

Bestwick

Wald

. Screening for prostate cancer. J Med Screen. Epub ahead of print 26 April 2026. 10.1177/09691413261440207.

Wald

Bestwick

Morris

. Multi-marker risk-based screening for prostate cancer. J Med Screen 2022; 29: 123–133.

Roobol

de Vos

Mansson

, et al. European study of prostate cancer screening – 23-year follow-up. N Engl J Med 2025; 393: 1669–1680.

Kasivisvanathan

Rannikko

Borghi

, et al. PRECISION Study group collaborators. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 2018; 378: 1767–1777.